Greyson International, Inc. Receives Successful Clinical Study Results

Greyson International, Inc. Receives Successful Clinical Study Results on Revolutionary Delivery System Trilexon®
Company to Hold Shareholder Conference Call Today at 4:15 p.m. EDT
BOCA RATON, Fla.—Oct. 29, 2009 — Greyson International, Inc. (GYSN.PK) announced today that it has received results from a third-party clinical study conducted on Trilexon®, a new delivery system designed by Greyson that improves the effectiveness of topical applications. Trilexon® Line Smoother, Trilexon® Eye Crème and Trilexon® Night Crème are the first skincare products to utilize the unique delivery system, which precisely delivers key ingredients to the appropriate areas through “messengers” in order to achieve higher effectiveness and more noticeable results.

“We are proud to announce the success of Trilexon® in a third-party clinical study,” said Greyson International CEO Harvey Tauman. “These findings validate what we have believed from the beginning—that Trilexon® is the latest and most effective technology to be introduced in the skincare market. This clinical study proves that Trilexon® delivers extraordinary results, above and beyond existing delivery systems found in today’s topical applications.”

The clinical study reviewed four different points, including Ph levels to determine the effectiveness of the delivery system, protein and skin lipid levels to determine the length of time the delivery system remains on the skin, time release of ingredients on the skin and skin barrier penetration of ingredients. On all four points, Trilexon® performed to the highest level, confirming that it is effective, remains on the skin, releases ingredients over time and penetrates the skin barrier to deliver active ingredients efficiently.
The independent study on Trilexon® was performed by Dr. Peter Pugliese, a world-renowned physician who has spent over 25 years studying specializing in aging mechanisms of human skin. Dr. Pugliese holds several patents, has published hundreds of articles and has lectured on every continent. He was awarded the Maison De Navarre Award for his contributions to cosmetic science. Dr. Pugliese has authored the textbook series Physiology of the Skin, which is a standard esthetic student reference. His latest textbook, Advanced Professional Skin Care, Medical Edition, replaced other teaching materials and has grown in use on a global level.

“As a chemist who has worked in the beauty and skincare industry for over 40 years, I am confident in stating that Trilexon® is one of the most significant advancements in delivery system technology that we have seen in decades,” said Charles Fox, head of research and development for Greyson International. “The results from this clinical study provide us with the scientific evidence that we need to authenticate its effectiveness as we move forward and market Trilexon® through our own products and through licensing opportunities to beauty, skincare, health and pharmaceutical companies around the world.”

Trilexon® also recently received trademark approval. Greyson International received confirmation that it is safe for use based on thorough safety testing on an independent panel of participants.
As a reminder, Greyson International will be hosting a conference call today, Thursday, Oct. 29, 2009, at 4:15 p.m. EDT with interested parties to discuss the Company’s recent developments and business strategy moving forward. Participation in the call is open to all interested parties. Participants may use the following phone numbers to take part in the call. Within the U.S. dial (Toll Free): 877-407-8035. International participants can dial: 201-689-8035.
About Greyson International, Inc.
Greyson International, Inc. is a research, development and marketing company that markets health and beauty aid products. Greyson has developed a new delivery method, the Trilexon® system, which will improve the effectiveness of virtually every topical application in today’s cosmetic market and every over-the-counter topical drug application. Trilexon® is a registered trademark of Greyson International. For more information, visit www.greysonproducts.com, join the Greyson Facebook group page by visiting www.facebook.com and searching “Greyson Products” or follow Greyson on Twitter at www.twitter.com/greysonproducts.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.